-transparent.png){kind=logo}
Effects of GTS-21 [3-(2,4-dimethoxybenzylidene)-anabaseine dihydrochloride], a selective nicotinic agonist, on locomotor activity and dopamine turnover were examined and compared to those of nicotine to test if GTS-21 exhibits side effects similar to those of nicotine. GTS-21 had no effect on locomotor activity in mice or dopamine turnover in rats. In contrast, nicotine produced a biphasic effect on locomotor activity. It also enhanced dopamine turnover rates in the striatum and cerebral cortex, suggesting the involvement of dopaminergic systems in the nicotine-induced changes in locomotor activity. GTS-21 exhibits fewer adverse effects, suggesting that it has therapeutic potential for cognitive disorders related to central cholinergic dysfunction.
M Nanri, and
N Kasahara, and
J Yamamoto, and
H Miyake, and
H Watanabe
October 1999,
Pharmacology, biochemistry, and behavior,
M Nanri, and
N Kasahara, and
J Yamamoto, and
H Miyake, and
H Watanabe
May 1994,
Brain research,
M Nanri, and
N Kasahara, and
J Yamamoto, and
H Miyake, and
H Watanabe
July 2011,
Shock (Augusta, Ga.),
M Nanri, and
N Kasahara, and
J Yamamoto, and
H Miyake, and
H Watanabe
August 1995,
Psychopharmacology,
M Nanri, and
N Kasahara, and
J Yamamoto, and
H Miyake, and
H Watanabe
November 1976,
Psychopharmacology,
M Nanri, and
N Kasahara, and
J Yamamoto, and
H Miyake, and
H Watanabe
September 2020,
Behavioural brain research,
M Nanri, and
N Kasahara, and
J Yamamoto, and
H Miyake, and
H Watanabe
August 2003,
Behavioural brain research,
M Nanri, and
N Kasahara, and
J Yamamoto, and
H Miyake, and
H Watanabe
January 2013,
Neuropharmacology,
M Nanri, and
N Kasahara, and
J Yamamoto, and
H Miyake, and
H Watanabe
January 2005,
Neurotoxicology and teratology,
M Nanri, and
N Kasahara, and
J Yamamoto, and
H Miyake, and
H Watanabe
January 2000,
Experimental aging research,
